{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:56:10Z","timestamp":1786136170195,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["227288\/Z\/23\/Z"],"award-info":[{"award-number":["227288\/Z\/23\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clp.2026.05.009","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T19:48:17Z","timestamp":1782503297000},"page":"741-761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Challenges in Designing Clinical Trials to Test New Drugs in the Pregnant and Breastfeeding Woman"],"prefix":"10.1016","volume":"53","author":[{"given":"Adeniyi","family":"Olagunju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Waitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Navaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clp.2026.05.009_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.clp.2019.02.015","article-title":"Challenges in designing clinical trials to test new drugs in the pregnant woman and fetus","volume":"46","author":"Turner","year":"2019","journal-title":"Clin Perinatol"},{"issue":"14","key":"10.1016\/j.clp.2026.05.009_bib3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMp1817420","article-title":"\u201cIs It Safe?\u201d - the many unanswered questions about medications and breast-feeding","volume":"380","author":"Byrne","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clp.2026.05.009_bib4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13104-024-06946-x","article-title":"Recruitment of pregnant and breastfeeding women in pharmacokinetic studies: strategies, opportunities, barriers, and recommendations","volume":"17","author":"Nakijoba","year":"2024","journal-title":"BMC Res Notes"},{"issue":"2","key":"10.1016\/j.clp.2026.05.009_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2352-4642(17)30173-6","article-title":"Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial","volume":"2","author":"Sharp","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"6","key":"10.1016\/j.clp.2026.05.009_bib6","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/cpt.3344","article-title":"Attaining equity of access to research: perspective on research in pregnancy and breastfeeding following dolores shockley lecture at ASCPT2024","volume":"116","author":"Waitt","year":"2024","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.clp.2026.05.009_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/bcp.14914","article-title":"Ethical issues in therapeutic use and research in pregnant and breastfeeding women","volume":"88","author":"Weld","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.clp.2026.05.009_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cpt.2048","article-title":"Optimizing pharmacology studies in pregnant and lactating women using lessons from HIV: a consensus statement","volume":"110","author":"Eke","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.clp.2026.05.009_bib9","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/S2214-109X(24)00445-5","article-title":"Scarcity of research on breastfeeding and Ebola diseases is placing the lives of women and infants at risk: a call to specific action","volume":"13","author":"Waitt","year":"2025","journal-title":"Lancet Global Health"},{"issue":"1","key":"10.1016\/j.clp.2026.05.009_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12910-024-01147-4","article-title":"\u2018Some parts of the consent form are written using complex scientific language\u2019: community perspectives on informed consent for research with pregnant and lactating mothers in Uganda","volume":"25","author":"Twimukye","year":"2024","journal-title":"BMC Med Ethics"},{"issue":"7","key":"10.1016\/j.clp.2026.05.009_bib11","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/cid\/ciz121","article-title":"Importance of prospective studies in pregnant and breastfeeding women living with human immunodeficiency virus","volume":"69","author":"Colbers","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.clp.2026.05.009_bib12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/cpt.2192","article-title":"Anti-infective dosing in special populations: pregnancy","volume":"109","author":"Hazenberg","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.clp.2026.05.009_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/bdrc.21096","article-title":"Thalidomide-induced teratogenesis: history and mechanisms","volume":"105","author":"Vargesson","year":"2015","journal-title":"Birth Defects Res C Embryo Today"},{"key":"10.1016\/j.clp.2026.05.009_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106806","article-title":"Clinical trials in pregnancy and the \u201cshadows of thalidomide\u201d: revisiting the legacy of Frances Kelsey","volume":"119","author":"Waggoner","year":"2022","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"10.1016\/j.clp.2026.05.009_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/jwh.2017.6857","article-title":"Beyond \u201cvessels and vectors\u201d: a global review of registered HIV-related clinical trials with pregnant women","volume":"28","author":"Wickremsinhe","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"10.1016\/j.clp.2026.05.009_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.vaccine.2019.01.011","article-title":"Pregnant women & vaccines against emerging epidemic threats: ethics guidance for preparedness, research, and response","volume":"39","author":"Krubiner","year":"2021","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.clp.2026.05.009_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25846","article-title":"Ending the evidence gap for pregnancy, HIV and co-infections: ethics guidance from the PHASES project","volume":"24","author":"Lyerly","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.clp.2026.05.009_bib19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s43856-022-00198-1","article-title":"Clinical trials and pregnancy","volume":"2","author":"Waitt","year":"2022","journal-title":"Commun Med (Lond)"},{"issue":"Suppl 3","key":"10.1016\/j.clp.2026.05.009_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12978-017-0430-2","article-title":"Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials","volume":"14","author":"Gomes","year":"2017","journal-title":"Reprod Health"},{"issue":"5","key":"10.1016\/j.clp.2026.05.009_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15265161.2011.560353","article-title":"Reframing the framework: toward fair inclusion of pregnant women as participants in research","volume":"11","author":"Lyerly","year":"2011","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.clp.2026.05.009_bib22","unstructured":"FDA. Clinical Lactation Studies: Considerations for Study Design. Guidance for Industry. 2019. Available at: https:\/\/www.fda.gov\/media\/124749\/download (Accessed 11 Jun 2026)"},{"key":"10.1016\/j.clp.2026.05.009_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fdsfr.2025.1712216","article-title":"Communicating medication risks in pregnancy: towards shared decision making","volume":"5","author":"Winterfeld","year":"2025","journal-title":"Front Drug Saf Regul"},{"issue":"1","key":"10.1016\/j.clp.2026.05.009_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jiph.2023.10.020","article-title":"Case fatality rate for Ebola disease, 1976-2022: a meta-analysis of global data","volume":"17","author":"Izudi","year":"2024","journal-title":"J Infect Public Health"},{"issue":"7","key":"10.1016\/j.clp.2026.05.009_bib28","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30194-8","article-title":"Pregnancy and breastfeeding in the context of Ebola: a systematic review","volume":"20","author":"Foeller","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.clp.2026.05.009_bib30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJM200007133430208","article-title":"Drug therapy for breast-feeding women","volume":"343","author":"Ito","year":"2000","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clp.2026.05.009_bib31","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/bcp.70325","article-title":"Physiologically based pharmacokinetic model combined with a clinical lactation study to determine doravirine concentrations in human breastmilk","volume":"92","author":"van der Wekken-Pas","year":"2026","journal-title":"Br J Clin Pharmacol"},{"issue":"15","key":"10.1016\/j.clp.2026.05.009_bib32","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1097\/QAD.0000000000002360","article-title":"Pharmacokinetics of maraviroc in plasma and breastmilk in a treatment-experienced perinatally HIV-1-infected woman","volume":"33","author":"Feiterna-Sperling","year":"2019","journal-title":"Aids"},{"key":"10.1016\/j.clp.2026.05.009_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1741-4520.1988.tb00968.x","article-title":"The use of animal models in understanding human teratogens","volume":"28","author":"Webster","year":"1988","journal-title":"Congenital Anom"},{"issue":"4","key":"10.1016\/j.clp.2026.05.009_bib34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1017\/S0963180115000079","article-title":"The flaws and human harms of animal experimentation","volume":"24","author":"Akhtar","year":"2015","journal-title":"Camb Q Healthc Ethics"},{"key":"10.1016\/j.clp.2026.05.009_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.733823","article-title":"Maternal-fetal pharmacology of drugs: a review of current status of the application of physiologically based pharmacokinetic models","volume":"9","author":"Chaphekar","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.clp.2026.05.009_bib36","first-page":"1","article-title":"Bridging the exposure-safety gap in the assessment of fetal exposure to maternal drugs","author":"Radziun","year":"2025","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"18","key":"10.1016\/j.clp.2026.05.009_bib43","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1016\/j.cell.2023.07.018","article-title":"Modeling post-implantation stages of human development into early organogenesis with stem-cell-derived peri-gastruloids","volume":"186","author":"Liu","year":"2023","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.clp.2026.05.009_bib45","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3390\/molecules15031987","article-title":"QSAR models for reproductive toxicity and endocrine disruption activity","volume":"15","author":"Novic","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.clp.2026.05.009_bib46","article-title":"Machine learning models for rat multigeneration reproductive toxicity prediction","volume":"13","author":"Liu","year":"2022","journal-title":"Front Pharmacol"},{"issue":"13","key":"10.1016\/j.clp.2026.05.009_bib47","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.3390\/jcm12134315","article-title":"Placenta-on-a-chip as an in vitro approach to evaluate the physiological and structural characteristics of the human placental barrier upon drug exposure: a systematic review","volume":"12","author":"Elzinga","year":"2023","journal-title":"J Clin Med"},{"issue":"6751","key":"10.1016\/j.clp.2026.05.009_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/science.adu9375","article-title":"Gastruloids enable modeling of the earliest stages of human cardiac and hepatic vascularization","volume":"388","author":"Abilez","year":"2025","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.clp.2026.05.009_bib49","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/s41467-024-45775-1","article-title":"Noncanonical function of folate through folate receptor 1 during neural tube formation","volume":"15","author":"Balashova","year":"2024","journal-title":"Nat Commun"},{"issue":"16","key":"10.1016\/j.clp.2026.05.009_bib50","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/bdr2.2229","article-title":"An improved multicellular human organoid model for the study of chemical effects on palatal fusion","volume":"115","author":"Wolf","year":"2023","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.clp.2026.05.009_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105068","article-title":"Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: thalidomide versus efavirenz as case studies","volume":"140","author":"Atoyebi","year":"2019","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"10.1016\/j.clp.2026.05.009_bib52","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nprot.2011.348","article-title":"The validated embryonic stem cell test to predict embryotoxicity in vitro","volume":"6","author":"Seiler","year":"2011","journal-title":"Nat Protoc"},{"key":"10.1016\/j.clp.2026.05.009_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1480845","article-title":"Organoid intelligence for developmental neurotoxicity testing","volume":"18","author":"Alam El Din","year":"2024","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"10.1016\/j.clp.2026.05.009_bib55","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/psp4.13232","article-title":"A tutorial on physiologically based pharmacokinetic approaches in lactation research","volume":"13","author":"Pansari","year":"2024","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"11","key":"10.1016\/j.clp.2026.05.009_bib56","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/pharmaceutics17111413","article-title":"The evolution and future directions of PBPK modeling in FDA regulatory review","volume":"17","author":"Li","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1450569","key":"10.1016\/j.clp.2026.05.009_bib57","first-page":"1","article-title":"Culturally appropriate terminologies in health research: a participatory study with pregnant and breastfeeding mothers in Uganda","volume":"9","author":"Nakijoba","year":"2025","journal-title":"Front Comm"},{"key":"10.1016\/j.clp.2026.05.009_bib58","doi-asserted-by":"crossref","first-page":"25","DOI":"10.12688\/aasopenres.13049.1","article-title":"\u201cWe shall have gone to a higher standard\u201d: training village heath teams (VHTs) to use a smartphone-guided intervention to link older Ugandans with hypertension and diabetes to care","volume":"3","author":"Mugisha","year":"2020","journal-title":"AAS Open Res"},{"issue":"1","key":"10.1016\/j.clp.2026.05.009_bib59","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/S2214-109X(22)00465-X","article-title":"The use of imagery in global health: an analysis of infectious disease documents and a framework to guide practice","volume":"11","author":"Charani","year":"2023","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.clp.2026.05.009_bib60","doi-asserted-by":"crossref","first-page":"510","DOI":"10.12688\/wellcomeopenres.19088.1","article-title":"It takes a village; involvement of village health teams to develop tools and resources to communicate about antiretroviral use in pregnancy and breastfeeding at community level in Uganda","volume":"8","author":"Nalugga","year":"2023","journal-title":"Wellcome Open Res"},{"issue":"3","key":"10.1016\/j.clp.2026.05.009_bib61","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00002018-200023030-00006","article-title":"Risk classification systems for drug use during pregnancy: are they a reliable source of information?","volume":"23","author":"Addis","year":"2000","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.clp.2026.05.009_bib62","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12936-024-05112-9","article-title":"Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure","volume":"23","author":"Abla","year":"2024","journal-title":"Malar J"},{"issue":"4","key":"10.1016\/j.clp.2026.05.009_bib66","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/archdischild-2016-311674","article-title":"Dutch paediatric pharmacotherapy Expertise Network NKFK Nederlands Kenniscentrum voor Farmacotherapie bij Kinderen. Developing a paediatric drug formulary for the Netherlands","volume":"102","author":"van der Zanden","year":"2017","journal-title":"Arch Dis Child"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:26:15Z","timestamp":1786134375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510826000576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0095510826000576"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2026.05.009","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in Designing Clinical Trials to Test New Drugs in the Pregnant and Breastfeeding Woman","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2026.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}